Kenalog For the treatment of mouth ulcers in Orabase ®

Kenalog
®
in Orabase
®
triamcinolone
acetonide
1 mg/g in emollient
dental paste
For the treatment of mouth ulcers
Kenalog in Orabase is used for relieving
tenderness, pain, inflammation and ulceration
of the inside of the mouth or the gums. The
sticky paste keeps the medicine on the
sore area and protects it while the medicine
relieves the soreness, reduces the swelling
and accelerates the healing process.
Directions for use:
• Press a small dab (about the size of a five cent coin) onto the sore area in your mouth,
allowing a thin film to develop on the ulcer. You may need to use a little more if the sore
is large.
• Ensure the sore area is covered completely, as coating the ulcer protects the area so the
healing can begin. If applied correctly, a smooth, slippery film should develop.
• Do not rub in or attempt to spread the paste as it might cause a gritty sensation in the
mouth and cause the paste to crumble.
• Apply the paste as often as recommended by your healthcare professional.
• The paste is best applied after meals and at bedtime to allow the medication to work
effectively.
• If symptoms persist for longer than 5 days, please consult your doctor, pharmacist or
dentist.
For more information on Kenalog in Orabase, please refer to the Consumer Medicines
Information (CMI) available from www.aspenpharma.com.au or speak with your healthcare
professional.
Always read the label. Use only as directed. If symptoms persist see your doctor/healthcare
professional. Your pharmacists’ advice is required.
Aspen Australia comprises Aspen Asia Pacific Pty Ltd (ABN 75 146 444 484) and its subsidiaries, including Aspen
Pharmacare Australia Pty Ltd (ABN 51 096 236 985), Aspen Pharma Pty Ltd (ABN 88 004 118 594), Orphan Holdings
Pty Ltd (ABN 50 115 816 209), Orphan Australia Pty Ltd (ABN 11 067 189 342), and Arrow Pharmaceuticals Pty Ltd
(ABN 17 003 144 170). All sales and marketing requests to: Aspen Pharmacare Pty Ltd, 34–36 Chandos Street,
St Leonards NSW 2065 | Tel. +61 2 8436 8300 aspen@aspenpharmacare.com.au | www.aspenpharma.com.au Product Information available via www. aspenpharma.com.au or call 1300 659 646. Prepared: March 2013. ASPXXX
Please review the full Product Information (PI) before
recommending, available from www.aspenpharma.com.au
or by calling 1300 656 755
Kenalog in Orabase (triamcinolone acetonide) Minimum Product Information Indications: Acute/chronic lesions of the
oral mucosa including recurrent ulcerative aphthous stomatitis; erosive lichen planus; denture stomatitis; traumatic lesions including
denture sore spots; desquamative gingivitis and stomatitis. Contraindications: Hypersensitivity to any component of the preparation;
presence of fungal or bacterial infections of the mouth or throat; herpetic lesions of known viral origin such as Herpes labialis or
intraoral lesions such as primary herpetic gingival stomatitis and herpanginas. Precautions: Symptoms of dizziness and weakness
in prolonged use; local irritation or sensitisation; patients with tuberculosis, peptic ulcer or diabetes mellitus; absence of lesion healing
after 7 days of treatment; not recommended in pregnancy (category C). Adverse Reactions: Prolonged administration may elicit
adrenal suppression, alteration of glucose metabolism, protein catabolism, peptic ulcer activations. Directions for Use: Press a small
dab (about 1cm) to the lesion until a thin film develops. A larger quantity may be required for coverage of some lesions. Do not rub in
or attempt to spread the paste. Apply at bedtime to permit maximum steroid contact with the lesion. Application 2 or 3 times a day
(preferably after meals) may be required for severe lesions.
Aspen Australia comprises Aspen Asia Pacific Pty Ltd (ABN 75 146 444 484) and its subsidiaries, including Aspen Pharmacare
Australia Pty Ltd (ABN 51 096 236 985), Aspen Pharma Pty Ltd (ABN 88 004 118 594), Orphan Holdings Pty Ltd (ABN 50 115
816 209), Orphan Australia Pty Ltd (ABN 11 067 189 342), and Arrow Pharmaceuticals Pty Ltd (ABN 17 003 144 170). All sales
and marketing requests to: Aspen Pharmacare Pty Ltd, 34–36 Chandos Street, St Leonards NSW 2065 | Tel. +61 2 8436
8300 aspen@aspenpharmacare.com.au | www.aspenpharma.com.au | Product Information available via
www. aspenpharma.com.au or call 1300 659 646. Prepared: March 2013. ASPXXX